These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2615152)

  • 21. [Affinity hemosorbent for the binding of atherogenic lipoproteins].
    Lopukhin IuM; Andrianova IP; Rabovskiĭ AB; Nalivaĭko ES; Kulaev DV
    Kardiologiia; 1986 Oct; 26(10):54-7. PubMed ID: 3795705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholesterol at birth and age 1: comparison of normal and hypercholesterolemic neonates.
    Tsang RC; Fallat RW; Glueck CJ
    Pediatrics; 1974 Apr; 53(4):458-70. PubMed ID: 4362901
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hypercholesteremia and the prevention of atheroma].
    Rey J; Rey F
    Arch Fr Pediatr; 1976 Oct; 33(8):821-33. PubMed ID: 185983
    [No Abstract]   [Full Text] [Related]  

  • 24. The heritable hyperlipoproteinemias and atherosclerosis.
    Glueck CJ; Fallat DW
    Adv Exp Med Biol; 1975; 63():305-16. PubMed ID: 173149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The dyslipoproteinemias.
    Brown DF
    Acta Diabetol Lat; 1972 Dec; 9 Suppl 2():18-52. PubMed ID: 4369284
    [No Abstract]   [Full Text] [Related]  

  • 26. [Serum lipoprotein level and coronary disease].
    Saprygin DB; Bielawski WI; Guslienko LS
    Przegl Lek; 1989; 46(7):599-603. PubMed ID: 2587788
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hypolipidemic effect of cholestyramine in patients affected by type II hyperlipoproteinemia].
    Sauvanet JP; Drouin P; Mejean L; Lambert D; Debry G
    Therapie; 1978; 33(5):615-22. PubMed ID: 217121
    [No Abstract]   [Full Text] [Related]  

  • 28. [Distribution of lipoprotein fractions in men with arteriosclerosis obliterans].
    Karádi I; Szabolcs Z; Szénási P; Hosszúfalusi N; Császár A; Kusztos R; Romics L
    Orv Hetil; 1989 Jul; 130(28):1489-92. PubMed ID: 2748165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Dietary treatment of hyperlipoproteinemia. Reduction of atherogenic lipid fractions in normal subjects].
    Weisweiler P
    Fortschr Med; 1985 Feb; 103(7):148-50. PubMed ID: 3972329
    [No Abstract]   [Full Text] [Related]  

  • 30. Serum lipoprotein lipids after gemfibrozil treatment.
    Schwandt P; Weisweiler P; Neureuther G
    Artery; 1979 Feb; 5(2):117-24. PubMed ID: 231950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current theories on the role of lipoproteins of different classes in the etiology of arteriosclerosis].
    Gasilin VS; Kurdanov KhA
    Ter Arkh; 1981; 53(8):130-8. PubMed ID: 7027512
    [No Abstract]   [Full Text] [Related]  

  • 32. The hyperlipoproteinemias.
    Patsch W; Patsch JR; Gotto AM
    Med Clin North Am; 1989 Jul; 73(4):859-93. PubMed ID: 2657266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-density lipoprotein and atheroma.
    Lancet; 1978 Dec; 2(8103):1291-2. PubMed ID: 82791
    [No Abstract]   [Full Text] [Related]  

  • 34. [Genetic aspects of primary atherogenic dyslipoproteinemia].
    Turpin G; Bruckert E
    C R Seances Soc Biol Fil; 1995; 189(5):905-17. PubMed ID: 8673636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Classification of hyperlipoproteinemias].
    Zabel R
    Dermatol Monatsschr; 1974 Feb; 160(2):134-50. PubMed ID: 4369507
    [No Abstract]   [Full Text] [Related]  

  • 36. [Dyslipoproteinemia as a coronary risk factor].
    Yamamura T
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():738-45. PubMed ID: 12735059
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices].
    Herrmann W; Reuter W
    Z Gesamte Inn Med; 1982 Dec; 37(24):830-3. PubMed ID: 6963524
    [No Abstract]   [Full Text] [Related]  

  • 38. [Immunological aspects of atherosclerosis].
    Osipov SG
    Klin Med (Mosk); 1989 Jan; 67(1):27-37. PubMed ID: 2654462
    [No Abstract]   [Full Text] [Related]  

  • 39. [Correction of hypercholesterolemia and dyslipoproteinemia by plasmapheresis in patients with stenocardia resistant to drug therapy].
    Orlov VN; Lekokhmakher SS; Porunova AK; Dobashina AN; Gavrilov AO
    Kardiologiia; 1988 Nov; 28(11):74-8. PubMed ID: 3230781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Possibilities of correction of mental disorders and dyslipoproteinemia in patients with neurocirculatory asthenia].
    Volkov VS; Lazarev VI; Vinogradov VF
    Klin Med (Mosk); 1990 Sep; 68(9):39-41. PubMed ID: 2290325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.